US Stock MarketDetailed Quotes

Solid Biosciences (SLDB)

Watchlist
  • 6.600
  • -0.260-3.79%
Close Jan 23 15:59 ET
  • 6.610
  • +0.010+0.15%
Post 17:07 ET
514.21MMarket Cap-2.66P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Solid Biosciences (SLDB) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-41.18%-33.47M
-74.28%-37.41M
-26.43%-31.85M
-6.19%-100.01M
-42.37%-29.65M
-32.47%-23.71M
21.84%-21.47M
10.01%-25.19M
3.88%-94.18M
39.61%-20.82M
Net income from continuing operations
-39.88%-45.78M
-57.47%-39.48M
-61.63%-39.28M
-29.87%-124.7M
-109.47%-42.6M
-55.98%-32.73M
-1.80%-25.07M
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
Operating gains losses
--850K
--900K
--1.65M
--4.75M
----
----
----
----
----
----
Depreciation and amortization
-7.16%376K
-68.74%386K
24.46%407K
-4.88%2.46M
129.11%488K
-31.12%405K
75.68%1.24M
-69.64%327K
7.18%2.58M
-60.48%213K
Other non cash items
-92.38%304K
14.48%664K
-2.47%553K
165.16%7.7M
150.68%2.57M
529.18%3.99M
--580K
--567K
115.72%2.91M
105.62%1.02M
Change In working capital
152.93%7.17M
-443.57%-2.54M
162.82%1.79M
132.14%2.85M
184.79%2.13M
132.46%2.84M
111.08%739K
-215.36%-2.85M
-140.39%-8.87M
14.68%-2.51M
-Change in prepaid assets
272.81%1.72M
-1,023.76%-4.08M
201.25%2.02M
-508.86%-2.45M
119.77%104K
-158.86%-993K
124.23%442K
-258.45%-2M
-83.82%598K
-233.50%-526K
-Change in payables and accrued expense
39.58%5.9M
187.21%1.98M
148.56%186K
190.17%6.97M
261.42%2.44M
18,478.26%4.23M
117.07%688K
82.32%-383K
-1,419.28%-7.73M
54.72%-1.51M
-Change in other current liabilities
-11.31%-443K
-10.49%-432K
12.05%-416K
3.40%-1.68M
12.66%-414K
10.36%-398K
---391K
---473K
---1.74M
---474K
Cash from discontinued investing activities
Operating cash flow
-41.18%-33.47M
-74.28%-37.41M
-26.43%-31.85M
-6.19%-100.01M
-42.37%-29.65M
-32.47%-23.71M
21.84%-21.47M
10.01%-25.19M
3.88%-94.18M
39.61%-20.82M
Investing cash flow
Cash flow from continuing investing activities
-312.06%-45.27M
-532.38%-32.73M
28.65%-27.46M
-266.02%-16.09M
-14.86%38.57M
55.40%-10.99M
89.27%-5.18M
-203.30%-38.49M
-83.62%9.69M
-31.47%45.3M
Net PPE purchase and sale
-466.67%-85K
-31.82%-377K
15.44%-126K
57.16%-649K
-121.11%-199K
96.08%-15K
46.64%-286K
70.55%-149K
37.27%-1.52M
89.49%-90K
Net investment purchase and sale
-311.85%-45.19M
-563.39%-32.44M
28.71%-27.34M
-237.78%-15.44M
-14.57%38.77M
54.76%-10.97M
89.75%-4.89M
-201.54%-38.35M
-62.71%11.2M
28.09%45.39M
Net other investing changes
--0
----
----
----
----
--0
--0
--5K
----
----
Cash from discontinued investing activities
Investing cash flow
-312.06%-45.27M
-532.38%-32.73M
28.65%-27.46M
-266.02%-16.09M
-14.86%38.57M
55.40%-10.99M
89.27%-5.18M
-203.30%-38.49M
-83.62%9.69M
-31.47%45.3M
Financing cash flow
Cash flow from continuing financing activities
-63.88%1.18M
-132.02%-1.6M
76.92%189.73M
3,821.75%122.44M
1,274.26%6.94M
3.26M
91.06%5M
107.24M
-95.83%3.12M
-99.32%505K
Net issuance payments of debt
-102.50%-243K
36.89%-142K
---135K
---473K
---128K
---120K
---225K
--0
----
----
Net common stock issuance
170.49%1.42M
-116.31%-1.66M
77.29%189.86M
4,006.12%122.12M
1,476.32%6.86M
---2.01M
301.02%10.18M
--107.09M
-95.90%2.97M
-99.40%435K
Proceeds from stock option exercised by employees
--0
31.17%202K
--0
436.49%794K
201.43%211K
--278K
97.44%154K
--151K
-27.09%148K
-35.78%70K
Net other financing activities
----
----
----
----
----
----
---286K
---4.83M
----
----
Cash from discontinued financing activities
Financing cash flow
-63.88%1.18M
-132.02%-1.6M
76.92%189.73M
3,821.75%122.44M
1,274.26%6.94M
--3.26M
91.06%5M
--107.24M
-95.83%3.12M
-99.32%505K
Net cash flow
Beginning cash position
44.08%140.86M
78.05%212.6M
8.36%82.19M
-51.76%75.85M
30.38%66.33M
4.67%97.76M
-28.28%119.41M
-51.76%75.85M
29.71%157.22M
0.02%50.87M
Current changes in cash
-146.73%-77.57M
-231.49%-71.75M
199.40%130.42M
107.79%6.34M
-36.50%15.86M
26.08%-31.44M
70.38%-21.64M
370.15%43.56M
-325.96%-81.37M
-76.51%24.98M
End cash Position
-4.58%63.29M
44.08%140.86M
78.05%212.6M
8.36%82.19M
8.36%82.19M
30.38%66.33M
4.67%97.76M
-28.28%119.41M
-51.76%75.85M
-51.76%75.85M
Free cash flow
-41.45%-33.56M
-73.72%-37.79M
-26.18%-31.98M
-5.19%-100.67M
-42.73%-29.85M
-29.78%-23.72M
22.31%-21.75M
11.09%-25.34M
5.24%-95.7M
40.82%-20.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -41.18%-33.47M-74.28%-37.41M-26.43%-31.85M-6.19%-100.01M-42.37%-29.65M-32.47%-23.71M21.84%-21.47M10.01%-25.19M3.88%-94.18M39.61%-20.82M
Net income from continuing operations -39.88%-45.78M-57.47%-39.48M-61.63%-39.28M-29.87%-124.7M-109.47%-42.6M-55.98%-32.73M-1.80%-25.07M19.18%-24.3M-11.67%-96.02M-34.22%-20.34M
Operating gains losses --850K--900K--1.65M--4.75M------------------------
Depreciation and amortization -7.16%376K-68.74%386K24.46%407K-4.88%2.46M129.11%488K-31.12%405K75.68%1.24M-69.64%327K7.18%2.58M-60.48%213K
Other non cash items -92.38%304K14.48%664K-2.47%553K165.16%7.7M150.68%2.57M529.18%3.99M--580K--567K115.72%2.91M105.62%1.02M
Change In working capital 152.93%7.17M-443.57%-2.54M162.82%1.79M132.14%2.85M184.79%2.13M132.46%2.84M111.08%739K-215.36%-2.85M-140.39%-8.87M14.68%-2.51M
-Change in prepaid assets 272.81%1.72M-1,023.76%-4.08M201.25%2.02M-508.86%-2.45M119.77%104K-158.86%-993K124.23%442K-258.45%-2M-83.82%598K-233.50%-526K
-Change in payables and accrued expense 39.58%5.9M187.21%1.98M148.56%186K190.17%6.97M261.42%2.44M18,478.26%4.23M117.07%688K82.32%-383K-1,419.28%-7.73M54.72%-1.51M
-Change in other current liabilities -11.31%-443K-10.49%-432K12.05%-416K3.40%-1.68M12.66%-414K10.36%-398K---391K---473K---1.74M---474K
Cash from discontinued investing activities
Operating cash flow -41.18%-33.47M-74.28%-37.41M-26.43%-31.85M-6.19%-100.01M-42.37%-29.65M-32.47%-23.71M21.84%-21.47M10.01%-25.19M3.88%-94.18M39.61%-20.82M
Investing cash flow
Cash flow from continuing investing activities -312.06%-45.27M-532.38%-32.73M28.65%-27.46M-266.02%-16.09M-14.86%38.57M55.40%-10.99M89.27%-5.18M-203.30%-38.49M-83.62%9.69M-31.47%45.3M
Net PPE purchase and sale -466.67%-85K-31.82%-377K15.44%-126K57.16%-649K-121.11%-199K96.08%-15K46.64%-286K70.55%-149K37.27%-1.52M89.49%-90K
Net investment purchase and sale -311.85%-45.19M-563.39%-32.44M28.71%-27.34M-237.78%-15.44M-14.57%38.77M54.76%-10.97M89.75%-4.89M-201.54%-38.35M-62.71%11.2M28.09%45.39M
Net other investing changes --0------------------0--0--5K--------
Cash from discontinued investing activities
Investing cash flow -312.06%-45.27M-532.38%-32.73M28.65%-27.46M-266.02%-16.09M-14.86%38.57M55.40%-10.99M89.27%-5.18M-203.30%-38.49M-83.62%9.69M-31.47%45.3M
Financing cash flow
Cash flow from continuing financing activities -63.88%1.18M-132.02%-1.6M76.92%189.73M3,821.75%122.44M1,274.26%6.94M3.26M91.06%5M107.24M-95.83%3.12M-99.32%505K
Net issuance payments of debt -102.50%-243K36.89%-142K---135K---473K---128K---120K---225K--0--------
Net common stock issuance 170.49%1.42M-116.31%-1.66M77.29%189.86M4,006.12%122.12M1,476.32%6.86M---2.01M301.02%10.18M--107.09M-95.90%2.97M-99.40%435K
Proceeds from stock option exercised by employees --031.17%202K--0436.49%794K201.43%211K--278K97.44%154K--151K-27.09%148K-35.78%70K
Net other financing activities ---------------------------286K---4.83M--------
Cash from discontinued financing activities
Financing cash flow -63.88%1.18M-132.02%-1.6M76.92%189.73M3,821.75%122.44M1,274.26%6.94M--3.26M91.06%5M--107.24M-95.83%3.12M-99.32%505K
Net cash flow
Beginning cash position 44.08%140.86M78.05%212.6M8.36%82.19M-51.76%75.85M30.38%66.33M4.67%97.76M-28.28%119.41M-51.76%75.85M29.71%157.22M0.02%50.87M
Current changes in cash -146.73%-77.57M-231.49%-71.75M199.40%130.42M107.79%6.34M-36.50%15.86M26.08%-31.44M70.38%-21.64M370.15%43.56M-325.96%-81.37M-76.51%24.98M
End cash Position -4.58%63.29M44.08%140.86M78.05%212.6M8.36%82.19M8.36%82.19M30.38%66.33M4.67%97.76M-28.28%119.41M-51.76%75.85M-51.76%75.85M
Free cash flow -41.45%-33.56M-73.72%-37.79M-26.18%-31.98M-5.19%-100.67M-42.73%-29.85M-29.78%-23.72M22.31%-21.75M11.09%-25.34M5.24%-95.7M40.82%-20.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -